Memphasys Ltd has released a press release.
KOL testings demonstrate Felix System outperforms DGC
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Memphasys
- FELIX System commercialisation, regulatory plan and trial
- Rights Issue Closure and Shortfall Notification
- $3.36 capital raising to accelerate FELIX commercialisation
- Suspension from Official Quotation
- Monash IVF clinical study enrols first patient using FELIX
Later from Memphasys
- Japan first commercial sale and first baby born using Felix
- Felix considered best method to treat cryopreserved semen
- Vitrolife sign Felix distribution agreement for Japanese mkt
- Felix System records 10 new live births in India
- Board and executive transition and capital raise
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys